Ignite Creation Date:
2024-05-05 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00420849
Status:
COMPLETED
Last Update Posted:
2012-05-21
First Post:
2007-01-09
Brief Title:
A Multicentre Single-arm Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
Sponsor:
Celgene Corporation
Organization:
Celgene
Study Overview
Official Title:
A Multicentre Single-arm Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
Status:
COMPLETED
Status Verified Date:
2012-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a multi-centre single-arm treatment study combining lenalidomide plus high dose dexamethasone
Subjects who qualify for participation will receive lenalidomide plus high dose dexamethasone in 4 week cycles Subjects will be seen every 2 weeks for the first 3 cycles of therapy and then every 4 weeks after the third cycle until disease progression is documented study drug is discontinued for any reason or lenalidomide becomes commercially available for this indication Assessments of safety and quality of life are performed during the study
Subjects who qualify for participation will receive lenalidomide plus high dose dexamethasone in 4 week cycles Subjects will be seen every 2 weeks for the first 3 cycles of therapy and then every 4 weeks after the third cycle until disease progression is documented study drug is discontinued for any reason or lenalidomide becomes commercially available for this indication Assessments of safety and quality of life are performed during the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2006-002517-12 | EUDRACT_NUMBER | None | None |